https://scholars.lib.ntu.edu.tw/handle/123456789/621179
Title: | Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials | Authors: | Simpson, Eric L Papp, Kim A Blauvelt, Andrew CHIA-YU CHU Hong, H Chih-Ho Katoh, Norito et al., |
Keywords: | PLACEBO | Issue Date: | 2022 | Publisher: | AMER MEDICAL ASSOC | Journal Volume: | 158 | Journal Issue: | 4 | Start page/Pages: | 404 | Source: | JAMA dermatology | Abstract: | Primary results from the Measure Up 1 and Measure Up 2 studies demonstrated upadacitinib efficacy and safety through 16 weeks in patients with atopic dermatitis. Longer-term outcomes remain unknown. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/621179 | ISSN: | 2168-6068 | DOI: | 10.1001/jamadermatol.2022.0029 |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.